Epidermal Growth Factor Reverses the Inhibitory Effects of the Bisphosphonate, Zoledronic Acid, on Human Oral Keratinocytes and Human Vascular Endothelial Cells In Vitro via the Epidermal Growth Factor Receptor (EGFR)/Akt/Phosphoinositide 3-Kinase (PI3K) Signaling Pathway. [electronic resource]
Producer: 20190408Description: 700-710 p. digitalISSN:- 1643-3750
- Apoptosis -- drug effects
- Bisphosphonate-Associated Osteonecrosis of the Jaw -- drug therapy
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Endothelial Cells -- drug effects
- Epidermal Growth Factor -- metabolism
- ErbB Receptors -- drug effects
- Human Umbilical Vein Endothelial Cells -- drug effects
- Humans
- Keratinocytes -- drug effects
- Neovascularization, Pathologic -- metabolism
- Neovascularization, Physiologic -- drug effects
- Nitric Oxide Synthase Type III -- metabolism
- Phosphatidylinositol 3-Kinases -- drug effects
- Proto-Oncogene Proteins c-akt -- drug effects
- Signal Transduction -- drug effects
- Zoledronic Acid -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.